This report analyzes the worldwide markets for DNA Probes-based Diagnostics in US$ Million by the following application areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, Molecular HLA (Human Leukocyte Antigen) Typing, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 63 companies including many key and niche players such as Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson & Company, Beckman Coulter, Inc., bioMerieux, Celera Group, Gen-Probe Incorporated, Genzyme Corporation, Luminex Molecular Diagnostics, QIAGEN, Roche Diagnostics, and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Table of Contents
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Infectious Diseases
Cancer
Genetic Predisposition
Identity/Forensics
Molecular HLA Testing
Other Diagnostic Applications
II. EXECUTIVE SUMMARY
1. MARKET DYNAMICS
Industry Overview
DNA Probes: Robust Growth Ahead
Decoding the Genetic Puzzle
Advantages of DNA-Probe Tests
Growth Drivers in a Nutshell
Growth Inhibitors in a Nutshell
Genetic Profiling of Pathogens: A Road Less Traveled
Roche's Entry into the Hall of Molecular Fame
DNA Technology: An Evolutionary Scan
An Era of Excellence: Tracking Landmark Breakthroughs in DNA Diagnostics
Opportunities
Market Trends/Issues
DNA Tests: Finding Use in Numerous Applications
World's Aging Population Drives the Popularity of DNA-Probe Tests
Reimbursements: "Under the Umbrella"
Evolution of New & Virulent Infectious Agents
The Enlightened Consumer of the 21st Century
Challenges In Widespread Deployment of DNA Based Diagnostics
Miniaturization: An Uphill Task
Improvements in Assay Capabilities
Information Handling & Processing: The Soft Side of Diagnostics
Integration: The Ultimate Challenge
The United States: Unraveling the Country's Edge in DNA based Diagnostics
2. DNA PROBES-BASED DIAGNOSTICS - A PRIMER
Diagnostic Gene Detection Products
Molecular Diagnostics: A Powerful Disease Detection Tool
DNA Probes-Based Products
Direct Detection of Target Sequence
Nucleic Acid Amplification
Gene Detection Using DNA Chips
Gene Detection by DNA Sequencing
The Dynamics of Key Enabling Technologies
In Situ Hybridization
PCR: Polymerase Chain Reaction
Chemiluminescence
Gen-Probe Tigris
DNA Chips
Key Players
Players in Molecular Diagnostics Market
Molecular Diagnostics - A Primer
Implications for Clinical Diagnostics
Need of the Hour
Molecular Diagnostics: Marking the Convergence of Numerous Technologies
Impact of the Human Genome Project
Molecular Diagnostics: Domain of the Developed Countries
"Tailored Patient Management": An Epitomized Future of Molecular Diagnostics
Futuristics: A Rumination
3. PRODUCT OVERVIEW
Background
Gene Probe Technology
What is DNA?
DNA Probes
Miniaturization: A Revolutionary Method in DNA Analysis
Gene Chip Technology
DNA Chips
Chromosome Painting Probes
Diagnostic Applications Based on DNA Probes: An Overview
Infectious Diseases
Respiratory Tract Infections
Diagnosis of Mycoplasma
DNA Probes to Detect Legionella Pneumophila
Detecting Tuberculosis Through Rapid Diagnostic Tests
OralDNA Labs(tm) Launches Two Dental Molecular Tests
5. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER
Luminex Molecular Introduces New xTAG(tm) Respiratory Viral Panel
Gen-Probe Introduces Aptima HPV Assay in Europe
Genzyme Genetics Introduces Prenatal Diagnosis and Carrier Testing
Affymetrix Launches New Cytogenetic Solution
Genekam Biotech Develops New Commercial DNA-Test to Detect Bird Flu
Seegene Launches Innovative DNA Test to Detect HPVs
deCODE Introduces deCODE T2
InterGenetics Introduces OncoVue
bioMerieux Unveils VIDAS C
bioMerieux Unveils NucliSENS EasyQ HPV
Applied Biosystems Launches SOLiD System
bioMerieux Introduces VIDAS(r) NT-proBNP
Abbott Molecular Rolls Out Six DNA Probes
PerkinElmer Launches Two New Multiplexing Platforms for Genomic Research
Kreatech Introduces First Complete Whole Genome Amplification Kit
Relative Genetics Introduces DNA Testing Services
Sorenson Launches Over-the-counter Paternity Test Kits
Kimball Genetics Introduces Warfarin Sensitivity DNA Test
bioMerieux Introduces TEMPO EB
Gen-Probe Launches PCA3 Assay
Genzyme Launches New KRAS Mutation Analysis
BD Launches New BD Viper(tm) System for Automating Molecular Diagnostic Testing Process
Affymetrix Unveils New GeneChip(r) Scanner with Higher Capacity Scanning
Genzyme Introduces EGFR Mutation Assay for Detecting Mutations
6. RECENT INDUSTRY ACTIVITY
Danaher Acquires Beckman Coulter
QIAGEN Partners with Genome Diagnostics
ZyGEM Snaps Up MicroLab Diagnostics
Metropolis Healthcare Partners with DDC
China Medical Technologies Obtains SFDA Approval
Nanobac Inks Merger Agreement with Eureka Genomics
Genzyme Enters into Licensing Agreement with Moffitt Cancer Center
Xceed Molecular Offers Gen-Probe License for Flow-Thru Chip(r) Technology
Dako Denmark's TOP2A FISH pharmDx Receives FDA Approval
Roche Diagnostics Receives Approval for Elecsys Anti-HCV Assay
bioMerieux and FIND Ink Memorandum of Understanding
BD Establishes Second Production Facility in China
Shanghai Kehua Bio-engineering and bioMerieux Establish Joint Venture
Quidel to Enter into Alliance with bioMerieux
Beckman Coulter Bags Rights to Hepatitis C Virus Test from Siemens
Affymetrix Enters into Partnership with Pathwork Diagnostics
Luminex Signs Distribution and Sales Agreement with Abbott
Gen-Probe to Acquire Innogenetics
Biocept to Introduce I.D.Rh(D)
DNA Testing Systems and DNAPrint Genomics Sign Sales Agreement
7. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER
Siemens Acquires Dade Behring
Sorenson Genomics Acquires Identigene
BioServe Takes Over Genomics Collaborative
Illumina Acquires Solexa
QIAGEN to Merge With eGene
NorDiag Acquires Genpoint
Cepheid Takes Over Sangtec Molecular Diagnostics
3M Enters into Collaboration with Gen-Probe
Luminex Corporation Completes Acquisition of Tm Bioscience
Ventana Medical Systems and C-Path to Collaborate with NCI and FDA
Ipsen and bioMerieux Enter into Theragnostics Agreement
Celera Acquires Atria Genetics
Celera Acquires Berkeley HeartLab
Beckman Coulter Enters into Partnership
Affymetrix Partners with IPSOGEN for In-Vitro Diagnostic Cancer Testing
Ventana Medical Systems Collaborates with Genentech
Siemens Medical Solutions Acquires Bayer's Diagnostic Division
Orchid Cellmark Acquires ReliaGene Technologies
GATC Enters into Collaboration for Developing DNA-based Diagnostic Test
Genetic Solutions and Catapult Merge to Establish Catapult Genetics
Grant Life Sciences Signs MoU with Alphagenics Diaco Biotechnologies
Gen-Probe and Millipore Ink Agreement to Market MTC-NI Test
QIAGEN Acquires Digene Corporation
BD Diagnostics and Quest Diagnostics Sign Agreement for BD Viper(tm) System
Enzo Biochem Plans to Produce Single Copy DNA Probes
Affymetrix Signs Two Agreements with Sysmex
Affymetrix and Partners HealthCare Enter into Collaboration
Affymetrix and Epigenomics Enter into an Agreement
Roche Introduces Elecsys TORCH Assays
QIAGEN to Take Over Gentra
LGC Acquires AGOWA to Extend German Operations
ENZ Receives Patent for Phosphate Labeling for Medical Research & DNA Diagnostic Products
TMC Achieves CE Mark for its Tag-It Cystic Fibrosis Test Kit
Toshiba Licenses Electrochemical Detection Technology to Antara
Affymetrix Licenses Multiple Patents to Invitrogen
Abbott Enters into Agreement with ALSI for Licensing ProGRP Biomarker
QIAGEN in Protein Crystallography Co-Marketing Agreement with ActiveSight
Warnex Acquires Pro-DNA Diagnostic
Celera Genomics Gains Complete Ownership of Celera Diagnostics
Gen-Probe Licenses Exclusive Rights for Diagnostic Tests Development from University of Michigan
QIAGEN Enters into Licensing Agreement with Applied Biosystems for Real-Time PCR Technologies
IGC Collaborates with Roche for Cancer Biomarker Discovery
Affymetrix Acquires ParAllele BioScience
QIAGEN Enters into Distribution Agreement with Osmetech Molecular Diagnostics
GlaxoSmithKline Acquires Canada-Based ID Biomedical Corp.
Gen-Probe Obtains FDA Approval for Marketing APTIMA
Gen-Probe Signs Purchasing Agreement with Roche
MP Biomedicals Acquires Qbiogene
Roche Diagnostics Receives FDA Approval for AmpliChip CYP450 Test
Ventana Launches ISH Tests
8. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Molecular (US)
Affymetrix, Inc. (US)
Becton, Dickinson & Company (US)
Beckman Coulter, Inc. (US)
bioMerieux (France)
Celera Group (US)
Gen-Probe Incorporated (US)
Genzyme Corporation (US)
Luminex Molecular Diagnostics (Canada)
QIAGEN (US)
Roche Diagnostics (Switzerland)
Siemens Healthcare Diagnostics, Inc. (US)
9. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 2: World Historic Review for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 3: World 15-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 4: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Infectious Disease Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 5: World Historic Review for DNA Probes-based Diagnostics (Infectious Disease Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 6: World 15-Year Perspective for DNA Probes-based Diagnostics (Infectious Disease Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 7: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Cancer Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 8: World Historic Review for DNA Probes-based Diagnostics (Cancer Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 9: World 15-Year Perspective for DNA Probes-based Diagnostics (Cancer Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 10: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Genetic Predisposition Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 11: World Historic Review for DNA Probes- based Diagnostics (Genetic Predisposition Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 12: World 15-Year Perspective for DNA Probes- based Diagnostics (Genetic Predisposition Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 13: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Identity/Forensics Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 14: World Historic Review for DNA Probes- based Diagnostics (Identity/Forensics Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 15: World 15-Year Perspective for DNA Probes-based Diagnostics (Identity/Forensics Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 16: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Molecular HLA Testing) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 17: World Historic Review for DNA Probes-based Diagnostics (Molecular HLA Testing) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 18: World 15-Year Perspective for DNA Probes-based Diagnostics (Molecular HLA) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 19: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics in Others Types of Diagnosis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 20: World Historic Review for DNA Probes-based Diagnostics in Others Types of Diagnosis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 21: World 15-Year Perspective for DNA Probes- based Diagnostics in Others Types of Diagnosis by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
A. Market Analysis
DNA-Based Diagnostic and Test Market: Progress towards a New Phase
DNA-Based Diagnostic Tests Picks Up Pace in New Streams
Rise of DNA-Based Home Testing Kits Market
Focus on Select Key Players
B. Market Analytics
Table 22: The US Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 23: The US Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 24: The US 15-Year Perspective for DNA Probes- based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2. CANADA
Market Analytics
Table 25: Canadian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 26: Canadian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 27: Canadian 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
3. JAPAN
Market Analytics
Table 28: Japanese Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 29: Japanese Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 30: Japanese 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4. EUROPE
Market Analytics
Table 31: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 32: European Historic Review for DNA Probes- based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 33: European 15-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 34: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 35: European Historic Review for DNA Probes- based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 36: European 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4a. FRANCE
Market Analytics
Table 37: French Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 38: French Historic Review for DNA Probes- based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 39: French 15-Year Perspective for DNA Probes- based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for 2003, 2011 & 2017 (includes correspondingGraph/Chart)
4b. GERMANY
Market Analytics
Table 40: German Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 41: German Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 42: German 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4c. ITALY
Market Analytics
Table 43: Italian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 44: Italian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 45: Italian 15-Year Perspective for DNA Probes- based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
Market Analytics
Table 46: The UK Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 47: The UK Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 48: The UK 15-Year Perspective for DNA Probes- based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4e. REST OF EUROPE
Market Analytics
Table 49: Rest of European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 50: Rest of European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 51: Rest of European 15-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
Market Analytics
Table 52: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 53: Asia-Pacific Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 54: Asia-Pacific 15-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, dentity/ Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
6. LATIN AMERICA
Market Analytics
Table 55: Latin American Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 56: Latin American Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 57: Latin American 15-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, dentity/ Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
DNA Probes-Based Diagnostics published by Global Industry Analysts, Inc. in May 1, 2012. This report consists of Pages: 493 and the price starts from US $ 4200.
The contents of this page may be different from the latest version. Please contact us for details.
